Canada Pulls Novartis Flu Vaccines Over Safety Concerns

Law360, New York (October 29, 2012, 1:34 PM EDT) -- Novartis AG on Friday agreed to suspend distribution of two seasonal flu vaccines in Canada at the behest of Canadian health officials, following a similar suspension in Europe after small, clumping particles were discovered in vaccines manufactured at a Novartis plant in Italy.

Health Canada said it had asked Novartis to temporarily halt distribution of flu vaccines Agriflu and Fluad until it has completed a review. The regulator’s public health division also advised all health care providers who have the vaccines not to use them until...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.